Skip to content

Abstract 7621: Discontinuation of Oral Anticoagulation After Successful Atrial Fibrillation Ablation: A Meta-Analysis of Randomized Controlled Trials

Nov 2026 · Circulation · 0 citations

Abstract

Background: The optimal strategy for long-term oral anticoagulation (OAC) after catheter ablation for atrial fibrillation (AF) remains uncertain. Although current guidelines recommend anticoagulation based on thromboembolic risk scores irrespective of rhythm status, this recommendation has not been validated by randomized controlled trials (RCTs). Methods: We included three RCTs, ODIn-AF, ALONE-AF, and OCEAN, enrolling patients at least 6 months post-ablation with no recurrent atrial arrhythmias. Primary efficacy outcomes were all-stroke and embolism (including cerebral emboli). The primary safety outcome was major bleeding. Secondary outcomes included clinically relevant non-major bleeding and other thromboembolic and bleeding events. Risk ratios (RR) with 95% confidence intervals (CI) were pooled using a random-effects model. Results: 2324 patients were included. Continued anticoagulation therapy did not significantly reduce the risk of all-stroke and embolism, at least 6 months post-catheter ablation [RR 0.58 (0.11-3.12); I 2 =54%]. OAC discontinuation was associated with lower risk of major bleeding [RR 0.33 (0.11-0.95); I 2 = 0%] and clinically relevant non-major bleeding [RR 0.40 (0.19-0.84); I 2 = 0%]. No significant differences were observed for other thromboembolic and bleeding events. Sensitivity analyses using per-protocol populations were significant only for a reduction in clinically relevant non-major bleeding [RR 0.33 (0.17-0.65); I 2 = 0%]. Conclusions: In patients remaining arrhythmia-free for at least 6 months after AF ablation, discontinuation of OAC reduces bleeding events without a statistically significant increase in thromboembolic risk, highlighting the need for larger, well-powered RCTs to better inform post-ablation anticoagulation strategies.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.